How Altasciences Helps Accelerate Global Drug Development with Ethnobridging Studies

1. How Altasciences Helps Accelerate Global Drug Development with Ethnobridging Studies

2. How Altasciences Helps Accelerate Global Drug Development with Ethnobridging Studies Altasciences is recognized as a leader in Ethnobridging clinical studies, and that has allowed them to play an integral role in accelerating global drug development. By outsourcing your next clinical trial with this contract research organization, your organization can utilize their expertise, resources, and facilities for a streamlined Ethnobridging study. Here are some of the ways Altasciences can help you and your company. The Altasciences Approach Altasciences has a unique approach to conducting Phase 1 clinical trials with an Ethnobridging component. First, they conduct research on Japanese, Chinese, and other Asian populations for Phase 1 clinical trials that takes place outside of the participants’ home countries. Clinical development is initiated with protocols that comply with the regulatory requirements of those countries to ensure that the clinical trial’s data is acceptable to the native country’s regulators. Second, Altasciences conducts research on all required populations simultaneously, rather than waiting until non-Asian clinical trials are complete. Streamlined Ethnobridging Strategies With more than 200 Ethnobridging studies completed since 2004, Altasciences has acquired significant expertise in performing Ethnobridging clinical trials. As a result, they have developed streamlined strategies for Ethnobridging studies, which can increase your molecule’s value and

3. help decrease development time. Altasciences offers two potential solutions in the U.S.—a single study after the target doses for a global study have been identified, or the addition of Asian study participants to first in human clinical trials. Recruiting Specific Populations from Existing Databases The key to a streamlined Ethnobridging clinical trial is a CRO that has access to the target population. Altasciences has access to Asian populations in the U.S. and maintains an active database of more than 9,000 potential participants. An average of 750 Asian participants are recruited yearly. When you partner with Altasciences, you get access to those databases and potential participants. Multilingual Staff Can Help Bridge the Gap Altasciences employs multilingual staff to help bridge the gap for non-English speaking participants. Altasciences’Phase 1 clinical trial units employ multilingual speaking nurses, technical staff, and recruitment teams that can facilitate community outreach and advertising. Having multilingual staff can help put potential participants at ease, making it easier for participants to answer questions in their native language. Altasciences’ employees understand their participants’ culture, therefore significantly improving recruiting and retention. Advertisements and Community Outreach Altasciences uses community outreach and advertisements to maintain a stream of new potential study participants. Once a specific population is identified, Altasciences uses multiple channels to reach that population, from grassroots recruitment to communication with local businesses and community leaders. The Altasciences team connects with community members by sponsoring international student organizations at colleges and universities and by strategically placing ads in Asian publications, on the radio, on TV, and on the internet. The staff also fosters relationships with the community through cultural events and festivals. Learn how Altasciences can help with https://www.altasciences.com/ Original Source: https://bit.ly/3vi40A2 your Ethnobridging clinical trial at